Acclarent logo — Our singular focus is to free #ENT patients to live better l...

Acclarent

Our singular focus is to free #ENT patients to live better lives.

Founded 2004 United States Irvine, United States 240 employees Venture round Total: $86.00M Biotechnology, Health Care

General Information

Company Name Acclarent
Founded Year 2004
Location United States Irvine, United States
Employees 240
Industries Biotechnology, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Acclarent. To contact Acclarent, visit acclarent.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Acclarent compare?

A PDF of Acclarent and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Acclarent soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Acclarent

Acclarent is a medical device company based in Irvine, CA, established in June 2004. The company's singular focus is to support Ear, Nose, and Throat (ENT) surgeons with minimally invasive technologies aimed at preserving nasal anatomy while addressing rhinosinusitis and persistent Eustachian Tube Dysfunction. Their flagship product, Balloon Sinuplasty technology, which was commercially launched in 2005, has been utilized by otolaryngologists in over 535,000 procedures. Acclarent operates within the biotechnology and health care industries, with headquarters in the United States. The company's last investment was a significant $26.00M Venture Round investment on January 12, 2009. The investors in this round included New Enterprise Associates, Meritech Capital Partners, Versant Ventures, Delphi Ventures, and Johnson & Johnson Development Corporation. Acclarent's dedication to addressing critical medical needs and its successful track record in the market make it an attractive prospect for potential venture capital investment.

Business keywords: Medical Device, ENT, Ear, Nose, Throat, Sinus, Balloon Sinuplasty, Minimally Invasive Technologies, Otolaryngologists, Eustachian Tube Dysfunction, Endoscopic Surgery, Innovative Devices, FDA Clearance, Catheter-based Tools, Navigation, Relieva, Integra LifeSciences

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $26.00M 5
New Enterprise Associates, Meritech Capital Partners +3
12 Jan 2009
Series C $35.00M 4
New Enterprise Associates, Meritech Capital Partners +2
23 Apr 2007
Series B $25.00M 1
New Enterprise Associates
20 Dec 2005
Seed Round Undisclosed -
01 Jun 2004

Acclarent Alternatives & Competitors

Acclarent vs
Inari Medical
Inari Medical United States

Improving lives in extraordinary ways by creating innovative solutions for both unmet and underserve...

Series C
1149 employees
Biotechnology, Health Care
Acclarent vs
TendoNova
TendoNova United States

Moving Orthopedics Forward

Venture round
14 employees
Biotechnology, Health Care

FAQ About Acclarent

Our singular focus is to free #ENT patients to live better lives.
Acclarent was founded in 2004.
Acclarent is headquartered in Irvine, United States.
Acclarent operates in Biotechnology and Health Care. Its work centres on Medical Device, ENT, Ear, Nose, Throat and Sinus.
Acclarent has approximately 240 employees.
Acclarent has completed 4 funding rounds, raising a total of $86.00M. The latest funding stage is Venture round.
Top alternatives and competitors to Acclarent include Inari Medical, TendoNova. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Acclarent and Inari Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Acclarent, https://bouncewatch.com/company/acclarent, updated 29 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes